UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option Biotech Investing
Sorrento Therapeutics CAR-T Manufacturing Capacity Expanded With Opening of East Coast GMP Site in Addition to Primary West Coast Facility Biotech Investing
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares Biotech Investing
